论文部分内容阅读
在如今高竞争压力的时代,零售药店面临的问题不仅有同行竞争的加剧,还有无法预测、无法左右的政策。故此,企业必须通过数据评估政策导向带来的影响,并从自身出发,提升运营管理能力,从而成功规避政策风险。医药行业政策不断在变,基药目录、限制最高零售价、限制陈列、限制客单价等等,层出不穷,药品生产厂家的商品也在不断更新换代中。
In the era of high competitive pressures, the problems facing retail pharmacies are not only exacerbated by peer competition, but also unpredictable and irrelevant policies. Therefore, companies must assess the impact of policy guidance through data and proceed from themselves to enhance their operational management capabilities so as to successfully evade policy risks. Pharmaceutical industry policies continue to change, the list of essential drugs, limit the maximum retail price, limit the display, limit the customer price, etc., after another, the drug manufacturer’s products are constantly upgrading.